WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-13 Cr | ₹1.01 Cr | ₹-15 Cr | ₹-44 Cr | ₹130 Cr |
What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹1.01 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-44 Cr |
| Mar2022 | ₹130 Cr |
How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹1.01 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-44 Cr | Negative | |
| Mar2022 | ₹130 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,952.8 Cr | -6.9% | -17.5% | 5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -6.9% |
-17.5% |
5.5% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses